Hepatitis C Virus
New findings from the United States describe advances in hepatitis C virus research
Published in Hepatitis Weekly, December 4th, 2006
Study 1: According to a study from the United States, in vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance.
"The hepatitis C virus (HCV) polymerase is an attractive target for the development of new and specific anti-HCV drugs. Herein, the characterization of the inhibitory effect of 2'-C-methyl-cytidine shows that it is a potent inhibitor of both genotype 1b and la HCV replicon replication, both of laboratory-optimized as well as of NS5B clinical isolates-chimera replicons," wrote S. Lepogam and colleagues, Roche...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-12-04)
More Articles from Hepatitis Weekly
- Hepatitis C Therapy
Maxygen's interferon alpha enters phase Ia clinical trial - Hepatitis A Virus
Study findings on hepatitis a virus are outlined in reports from Johann Wolfgang Goethe University - Hepatitis B Virus
Research from Blood Center provides new data on hepatitis b virus - Hepatitis B Virus
Studies from Institute of Tropical Medicine, Department of Parasitology yield new data on hepatitis b virus - Hepatitis B Virus
Studies from Zhejiang University reveal new findings on hepatitis b virus - Hepatitis B Virus
Study results from Nanyang Technological University, College of Engineering broaden understanding of hepatitis b virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
